Durvalumab
| CAS No. | 1428935-60-7 | Cat. No. | BCP25841 |
| Name | Durvalumab | ||
| Synonyms | |||
| Formula | C6502H10018N1742O2024S42 | M. Wt | 146.3 kg/mol |
| Description | Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | PD 1/PD L1 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.